2 hours ago
10X Genomics (TXG) Stock Surges 4% Following Cleveland Clinic Bladder Cancer Research Agreement
10X Genomics (TXG) stock climbed 3.8% after revealing a Cleveland Clinic partnership for bladder cancer research using Flex Apex, Xenium, and Atera platforms.
The post 10X Genomics (TXG) Stock Surges 4% Following Cleveland Clinic Bladder Cancer Research Agreement appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
Market Movers Today: Warsh’s Fed Debut, SpaceX-Cursor Deal, and Energy Slide
- 2 hours ago
SpaceX (SPCX) vs AST SpaceMobile (ASTS): A Complete Investment Comparison for 20...
- 2 hours ago
CrowdStrike (CRWD) Stock Climbs on Enhanced AWS Security Integration
- 2 hours ago
Robinhood (HOOD) Stock Soars 11% on Workforce Cuts and Bullish Analyst Moves
- 3 hours ago
Snap (SNAP) Stock Climbs 3% Following Launch of $2,195 Standalone AR Glasses